196 related articles for article (PubMed ID: 31811111)
1. A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma.
Lin Y; Liang R; Ye J; Li Q; Liu Z; Gao X; Piao X; Mai R; Zou D; Ge L
Aging (Albany NY); 2019 Dec; 11(23):11157-11169. PubMed ID: 31811111
[TBL] [Abstract][Full Text] [Related]
2. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
[TBL] [Abstract][Full Text] [Related]
5. Identifying 13 Hub Genes Associated with Progression and Prognosis of Hepatocellular Carcinoma with Weighted Gene Co-Expression Network Analysis.
Liu Y; Cheng R; Chang Q; Wu Y; Liu C; Liu Y; Wu X; Cheng L; Hu L; Yin J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):59-69. PubMed ID: 34587436
[TBL] [Abstract][Full Text] [Related]
6. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
9. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
10. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
11. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
12. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
14. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.
Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q
Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
[TBL] [Abstract][Full Text] [Related]
16. Functional and topological properties in hepatocellular carcinoma transcriptome.
Drozdov I; Bornschein J; Wex T; Valeyev NV; Tsoka S; Malfertheiner P
PLoS One; 2012; 7(4):e35510. PubMed ID: 22539975
[TBL] [Abstract][Full Text] [Related]
17. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
19. Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma.
Shang YK; Li F; Zhang Y; Liu ZK; Wang ZL; Bian H; Chen ZN
Medicine (Baltimore); 2018 Jun; 97(23):e10892. PubMed ID: 29879025
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma.
Wang X; Gong Y; Deng T; Zhang L; Liao X; Han C; Yang C; Huang J; Wang Q; Song X; Zhang T; Yu T; Zhu G; Ye X; Peng T
J Cell Biochem; 2019 Oct; 120(10):18246-18265. PubMed ID: 31211449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]